Cargando…
Senescence: a double-edged sword in beta-cell health and failure?
Cellular senescence is a complex process marked by permanent cell-cycle arrest in response to a variety of stressors, and acts as a safeguard against the proliferation of damaged cells. Senescence is not only a key process underlying aging and development of many diseases, but has also been shown to...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203573/ https://www.ncbi.nlm.nih.gov/pubmed/37229454 http://dx.doi.org/10.3389/fendo.2023.1196460 |
_version_ | 1785045664812498944 |
---|---|
author | Varghese, Sneha S. Dhawan, Sangeeta |
author_facet | Varghese, Sneha S. Dhawan, Sangeeta |
author_sort | Varghese, Sneha S. |
collection | PubMed |
description | Cellular senescence is a complex process marked by permanent cell-cycle arrest in response to a variety of stressors, and acts as a safeguard against the proliferation of damaged cells. Senescence is not only a key process underlying aging and development of many diseases, but has also been shown to play a vital role in embryogenesis as well as tissue regeneration and repair. In context of the pancreatic beta-cells, that are essential for maintaining glucose homeostasis, replicative senescence is responsible for the age-related decline in regenerative capacity. Stress induced premature senescence is also a key early event underlying beta-cell failure in both type 1 and type 2 diabetes. Targeting senescence has therefore emerged as a promising therapeutic avenue for diabetes. However, the molecular mechanisms that mediate the induction of beta-cell senescence in response to various stressors remain unclear. Nor do we know if senescence plays any role during beta-cell growth and development. In this perspective, we discuss the significance of senescence in beta-cell homeostasis and pathology and highlight emerging directions in this area that warrant our attention. |
format | Online Article Text |
id | pubmed-10203573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102035732023-05-24 Senescence: a double-edged sword in beta-cell health and failure? Varghese, Sneha S. Dhawan, Sangeeta Front Endocrinol (Lausanne) Endocrinology Cellular senescence is a complex process marked by permanent cell-cycle arrest in response to a variety of stressors, and acts as a safeguard against the proliferation of damaged cells. Senescence is not only a key process underlying aging and development of many diseases, but has also been shown to play a vital role in embryogenesis as well as tissue regeneration and repair. In context of the pancreatic beta-cells, that are essential for maintaining glucose homeostasis, replicative senescence is responsible for the age-related decline in regenerative capacity. Stress induced premature senescence is also a key early event underlying beta-cell failure in both type 1 and type 2 diabetes. Targeting senescence has therefore emerged as a promising therapeutic avenue for diabetes. However, the molecular mechanisms that mediate the induction of beta-cell senescence in response to various stressors remain unclear. Nor do we know if senescence plays any role during beta-cell growth and development. In this perspective, we discuss the significance of senescence in beta-cell homeostasis and pathology and highlight emerging directions in this area that warrant our attention. Frontiers Media S.A. 2023-05-09 /pmc/articles/PMC10203573/ /pubmed/37229454 http://dx.doi.org/10.3389/fendo.2023.1196460 Text en Copyright © 2023 Varghese and Dhawan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Varghese, Sneha S. Dhawan, Sangeeta Senescence: a double-edged sword in beta-cell health and failure? |
title | Senescence: a double-edged sword in beta-cell health and failure? |
title_full | Senescence: a double-edged sword in beta-cell health and failure? |
title_fullStr | Senescence: a double-edged sword in beta-cell health and failure? |
title_full_unstemmed | Senescence: a double-edged sword in beta-cell health and failure? |
title_short | Senescence: a double-edged sword in beta-cell health and failure? |
title_sort | senescence: a double-edged sword in beta-cell health and failure? |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203573/ https://www.ncbi.nlm.nih.gov/pubmed/37229454 http://dx.doi.org/10.3389/fendo.2023.1196460 |
work_keys_str_mv | AT varghesesnehas senescenceadoubleedgedswordinbetacellhealthandfailure AT dhawansangeeta senescenceadoubleedgedswordinbetacellhealthandfailure |